Home > Boards > US Listed > Medical - Equipment > Titan Medical Inc. (TMDI)

I posted this list of links before, but

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
66Mustang Member Profile
 
Followed By 12
Posts 1,916
Boards Moderated 0
Alias Born 05/12/16
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 5/11/2021 2:53:42 PM
Titan Medical to Report First Quarter 2021 Financial Results May 17, 2021 Business Wire - 5/4/2021 7:30:00 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 4/26/2021 6:06:20 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/22/2021 7:31:27 AM
Titan Medical Expands Senior Leadership Team Business Wire - 4/22/2021 7:30:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/16/2021 10:54:22 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 4/5/2021 7:31:18 AM
Titan Medical to Present at Bloom Burton & Co. Healthcare Investor Conference Business Wire - 4/5/2021 7:30:00 AM
Annual Report (foreign Private Issuer) (40-f) Edgar (US Regulatory) - 4/1/2021 6:10:48 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 3/25/2021 6:05:18 AM
Post-effective Amendment to Registration Statement (pos Am) Edgar (US Regulatory) - 3/18/2021 5:30:30 PM
Titan Medical to Participate in Upcoming Investor Conferences Business Wire - 3/10/2021 6:45:00 AM
Titan Medical provides corporate update ahead of investor conference Seeking Alpha - 3/9/2021 1:37:17 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 3/9/2021 9:56:55 AM
Titan Medical Issues Corporate Update Business Wire - 3/9/2021 6:45:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/26/2021 9:11:17 AM
Titan Medical Announces Closing of US $23M Bought Deal Offering Including Full Exercise of Over-Allotment Option Business Wire - 2/24/2021 9:22:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/22/2021 9:28:18 AM
Titan Medical reports FY results Seeking Alpha - 2/22/2021 9:13:57 AM
Titan Medical Reports Year-End 2020 Financial Results Business Wire - 2/22/2021 8:56:00 AM
Titan Medical Launches “Titan Living Labs” Showcasing a Behind-the-Scenes Look at Product Development Business Wire - 2/16/2021 7:00:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/10/2021 10:19:45 AM
Titan Medical to Report Year-End 2020 Financial Results and Host Webcast on February 22, 2021 Business Wire - 2/9/2021 10:21:00 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 2/8/2021 7:00:51 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/27/2021 5:00:54 PM
66Mustang   Tuesday, 07/14/20 09:16:47 AM
Re: None
Post # of 127219 
I posted this list of links before, but I will re-post the content here (instead of making folks chase these links through my older post). This time I will add pertinent highlights from each Mazor press release so you can see what we might be looking at if the Mazor deal is the model for ours, since this apparently is Medtronic's acquisition method.


https://investors.mazorrobotics.com/press-releases?item=128
May 2016, first PR, a co-development agreement and initial equity investment ($11.9M); milestones due end of 2017, 2 more tranches available with milestones met.

https://investors.mazorrobotics.com/press-releases?item=133
Aug 2016, first milestone met in July so second tranche of $20M paid.

https://investors.mazorrobotics.com/press-releases?item=149
Aug 2017, entering third phase of agreement early, third tranche of $40M paid, Medtronic assumes exclusive distribution of Mazor X system (Mazor's halo product) - still no public mention of acquisition but Mazor can't even sell the Mazor X system any more - not hard to know where this is going by now!

https://investors.mazorrobotics.com/press-releases?item=151
Sept 2017, third tranche closed (the $40M above) plus MDT bought an additional 1.21M warrants (ADSs, actually - same difference) at a 15% premium over current share price.

https://investors.mazorrobotics.com/press-releases?item=170
Sept 2018, acquisition announced, expected to close Jan 2019.

https://investors.mazorrobotics.com/2018-11-19-Mazor-Robotics-Shareholders-Approve-Merger-Agreement-With-Medtronic
shareholders approve "merger" with 95% of votes cast in favor.

This last one is the last post under the old Mazor robotics web site; after that... they were Medtronic!

If our deal was a one shot deal for our tech, it would be done; there would be no tranches for upcoming milestones, they wouldn't give a freak about what we do with their money afterwards. The only reason we have to meet milestones is because it is a co-development effort whereby we are developing their single port offering for them to market after, and possibly even before, the acquisition closes.

The transfer of licensed rights to our patent portfolio is to have their (MDT's) ducks in a row legally and own the rights to the technology by the time they start to market the device. If someone wants a real project for full confirmation, they can start digging through patent websites to see if they can find similar IP transition documents for the Mazor/MDT deal; in my mind that would take this from 97% sure to 99.9% sure that this is exactly what is going on. Pretty strong odds no matter what.

In the first PR, they describe the three tranches and the third tranche is called a "potential third tranche" which hints that they wanted the option to complete the acquisition early. I'd be okay with that, too.

MDT set very achievable milestones with Mazor to ensure they could be met, and hence they were all met early and agreements were modified accordingly to speed up the acquisition. Our first milestone had a four month window and we hit it in two days. Our next milestone is due in October; I'm betting we hit it late August - maybe mid-September at the latest.

Folks, this is the highway that Medtronic has paved and they've driven this highway before. They know what they're doing, and if anyone can't see it with this step-by-step Medtronic Acquisition Guide laid out for them, then they have an ulterior motive.

The deal closes in December 2018. 19 months start to finish from a PR standpoint, but again, there had to be some prep work in advance that both parties were involved in; I still figure the Titan/MDT deal has been in the works since late January/early February.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences